Industry Reacts Negatively To Stent Price Capping By NPPA
Express Healthcare|March 2017

It will deprive patients of latest tech advancements, say medical technology industry, associations.

Industry Reacts Negatively To Stent Price Capping By NPPA

Government of India recently issued a notification to fix ceiling prices of coronary stents to eventually bring down the cost of coronary stents, currently hiked by about 380 per cent.

The story so far...

According to a recent data published by National Interventional Council (NIC), surgeries involving stent procedures have tripled over the last five years. In the absence of proper regulatory framework, a patient undergoing such a procedure ends up paying anywhere between 10 to 1000 per cent more than the actual cost of stent, pushing the cost of medical procedure to around ₹200,000 – 250,000.

Nonetheless, recently the government has included all types of stents – drug-eluting stents (DES), bioresorbable vascular scaffold (BVS) and bare metal stents (BMS) in the National List of Essential Medicines (NLEM) and has fixed their ceiling prices at ₹29,600 for DES and BVS and ₹7,260 for BMS respectively. The cap on prices is with immediate effect. It will lead to a reduction in stent prices by 85 per cent. Reportedly, this move would directly result in the reduction of total procedure cost by around 25-30 per cent.

Ananth Kumar, Union Minister for Chemicals & Fertilizers and Parliamentary Affairs, asserted that the step is a major decisive action on the unethical margins charged at each stage in the supply chain of coronary stents. The Ministry of Health and Family Welfare had included Coronary Stents in the National List of Essential Medicines, 2015 (NLEM, 2015) on July 19, 2016 and the Ministry of Chemicals and Fertilizers incorporated Coronary Stents in Schedule I of the Drug Prices Control Order (DPCO), 2013 on December 21, 2016.

However, the decision has not found favour with many in the stent industry. The critics believe that the move will not lead to the anticipated results, on the contrary it could have adverse effects.

Denne historien er fra March 2017-utgaven av Express Healthcare.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra March 2017-utgaven av Express Healthcare.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA EXPRESS HEALTHCARESe alt
Healthcare Communication In India
Express Healthcare

Healthcare Communication In India

Dr Alexander Thomas, President, Association of Healthcare Providers - India (AHPI) and Divya Alexander, Research Consultant, in a first of a series provide detailed insights on healthcare communication that explores its different aspects in an Indian context

time-read
6 mins  |
March 2020
The growth story
Express Healthcare

The growth story

Himanshu Baid, Managing Director, Poly Medicure elucidates on how Poly Medicure has served the medical fraternity for over 22 years and owns more than 215 patents and continues to file new patents for new technologies and devices they are developing with the help of its R&D team

time-read
2 mins  |
March 2020
Main objective of Indian Joint Registry is to help patient safety, bring stability to the market
Express Healthcare

Main objective of Indian Joint Registry is to help patient safety, bring stability to the market

In the wake of several patients suffering from the impact of faulty hip implants, it is vital that India has a national joint registry to track such patients and avoid future episodes. Richard Armstrong, Head, Health Registries, Northgate Public Services tells Viveka Roychowdhury about the response to the Indian Joint Registry

time-read
4 mins  |
March 2020
Express Healthcare

UNDERSTANDING THE RELEVANCE OF HEALTHCARE RESEARCH

India as a nation has followed the west for decades when it comes to research-based treatments. The sun is fast setting on this methodology and there is a massive need to invest in healthcare research in the country

time-read
8 mins  |
March 2020
I have witnessed the steady technical advances in ultrasound
Express Healthcare

I have witnessed the steady technical advances in ultrasound

Dr BS Rama Murthy, Consultant Radiologist, Srinivasa Ultrasound Scanning Centre and Chief Patron, Medical Ultrasound Society of Karnataka, Coordinator – Fetal Foundation of India, talks about the evolution of ultrasound and how foetal imaging has improved over the years, in an interaction with Express Healthcare

time-read
4 mins  |
March 2020
Radiology has a bright future and has been at the forefront of healthcare
Express Healthcare

Radiology has a bright future and has been at the forefront of healthcare

Radiology has a major role to play when it comes to healthcare. Dr Piyush Saxena, Consultant Radiologist and Chief of MR imaging, Vishesh Hospital and Diagnostics, Indore, MP in an exclusive conversation with Express Healthcare disscuses the impact of radiology on healthcare and how newer innovations from GE Healthcare has helped improve healthcare delivery as well as patient comfort

time-read
4 mins  |
March 2020
The Pill For India's Ailing Medical Eductaion System
Express Healthcare

The Pill For India's Ailing Medical Eductaion System

Medical education in India is mired with a host of controversies and is trudging along a rough path.

time-read
6 mins  |
February 2020
RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai
Express Healthcare

RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai

Invites renowned Japanese cardiac interventionist, Dr Kinzo Ueda to India to share his experiences and insights with cardiologists at Apollo Hospitals and Sri Ramachandra Institute of Higher Education and Research

time-read
8 mins  |
February 2020
Roche Diagnostics partners with SRL Dr Avinash Phadke Lab
Express Healthcare

Roche Diagnostics partners with SRL Dr Avinash Phadke Lab

Roche’s first partner for cobas pro solution is SRL Dr Avinash Phadke Lab in Mumbai. The solution promises to offer greater automation, flexibility and simplified workflow to support better clinical outcomes for patients

time-read
5 mins  |
February 2020
Pharmacogenomics- Essential to end the era of trial and error medicine
Express Healthcare

Pharmacogenomics- Essential to end the era of trial and error medicine

Chandni Luthra, Co-Founder, FutureMed elucidates on the impact that trial and error has had on patients earlier, but in today's age adverse drug reactions is considered to be the fourth leading cause of death worldwide and has almost doubled in India in the last three years

time-read
3 mins  |
February 2020